Abstract
Eating disorders (EDs) are serious illnesses whose treatment, particularly with children and adolescents, requires sophisticated integration of skills and techniques from the armamentarium of evidence-based treatments targeting EDs and associated symptoms. Especially difficult to treat are cognitive impairments, because they are both disease specific (e.g., cognitive distortions related to the body itself) and more general (e.g., difficulties with uncertainty). This paper discusses cognitive impairments in EDs that involve difficulty coping with uncertainty and the associated implications on emotional and behavioral functioning. A set of skills to assess and increase adaptive coping with uncertainty is discussed in depth. Clinicians are strongly encouraged to target cognitive difficulties such as intolerance of uncertainty in ED treatment, as they can otherwise significantly interfere with one of the strongest predictors of successful outcomes - behavior change.
Keywords: Eating disorders, anorexia nervosa, intolerance of uncertainty, psychotherapy, cognitive therapy, behavioral therapy, acceptance and commitment therapy, mindfulness, meditation, breathwork
Adolescent Psychiatry
Title: Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it
Volume: 1 Issue: 4
Author(s): Maria-Christina Stewart
Affiliation:
Keywords: Eating disorders, anorexia nervosa, intolerance of uncertainty, psychotherapy, cognitive therapy, behavioral therapy, acceptance and commitment therapy, mindfulness, meditation, breathwork
Abstract: Eating disorders (EDs) are serious illnesses whose treatment, particularly with children and adolescents, requires sophisticated integration of skills and techniques from the armamentarium of evidence-based treatments targeting EDs and associated symptoms. Especially difficult to treat are cognitive impairments, because they are both disease specific (e.g., cognitive distortions related to the body itself) and more general (e.g., difficulties with uncertainty). This paper discusses cognitive impairments in EDs that involve difficulty coping with uncertainty and the associated implications on emotional and behavioral functioning. A set of skills to assess and increase adaptive coping with uncertainty is discussed in depth. Clinicians are strongly encouraged to target cognitive difficulties such as intolerance of uncertainty in ED treatment, as they can otherwise significantly interfere with one of the strongest predictors of successful outcomes - behavior change.
Export Options
About this article
Cite this article as:
Stewart Maria-Christina, Difficulty with Uncertainty: How It Presents in Eating Disorders and What We Can Do About it, Adolescent Psychiatry 2011; 1 (4) . https://dx.doi.org/10.2174/2210676611101040296
DOI https://dx.doi.org/10.2174/2210676611101040296 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Salutary Properties of YC-1 in the Cardiovascular and Hematological Systems
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design Elucidation of Pathophysiology and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Clinical Impacts in Cardiovascular Molecular Imaging: the Example of Cardiac Sympathetic Imaging in Heart Failure
Current Medical Imaging Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Current Cancer Drug Targets Current Issues in Intravenous Fluid Use in Hospitalized Children
Reviews on Recent Clinical Trials MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases
Current Drug Targets Marine Depsipeptides as Promising Pharmacotherapeutic Agents
Current Protein & Peptide Science Antidepressants and Sleep: Neurophysiology and Clinical Correlates
Current Psychiatry Reviews Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance
Combinatorial Chemistry & High Throughput Screening Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews Diabetic Cardiomyopathy: Clinical and Metabolic Approach
Current Vascular Pharmacology Lappaconitine: Influence of Halogen Substituent on the Antiarrhythmic Activity
Cardiovascular & Hematological Agents in Medicinal Chemistry Postconditioning: A New Paradigm for Myocardial Protection?
Current Cardiology Reviews Conference Report: 12<sup>th</sup> International Congress on Neuroprotective Agents (ICNA), Charlottesville, VA, USA September 28, 2014-Ocobert 01, 2014
CNS & Neurological Disorders - Drug Targets Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
Recent Patents on Cardiovascular Drug Discovery Current Immunotherapies for Renal Cell Carcinoma
Current Molecular Pharmacology Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science